The DOI matches its Crossref record; 214 of the 215 references it cites were found in a registry or an index; none of the 23 sources its claims cite is checked for support yet.
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Open accessAbstract
IMPORTANCE: Primary care clinicians find managing chronic pain challenging. Evidence of long-term efficacy of opioids for chronic pain is limited. Opioid use is associated with serious risks, including opioid use disorder and overdose. OBJECTIVE: To provide recommendations about opioid prescribing for primary care clinicians treating adult patients with chronic pain outside of active cancer treatment, palliative care, and end-of-life care. PROCESS: The Centers for Disease Control and Prevention (CDC) updated a 2014 systematic review on effectiveness and risks of opioids and conducted a supplemental review on benefits and harms, values and preferences, and costs. CDC used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework to assess evidence type and determine the recommendation category. EVIDENCE SYNTHESIS: Evidence consisted of observational studies or randomized clinical trials with notable limitations, characterized as low quality using GRADE methodology. Meta-analysis was not attempted due to the limited number of studies, variability in study designs and clinical heterogeneity, and methodological shortcomings of studies. No study evaluated long-term (≥1 year) benefit of opioids for chronic pain. Opioids were associated with increased risks, including opioid use disorder, overdose, and death, with dose-dependent effects. RECOMMENDATIONS: There are 12 recommendations. Of primary importance, nonopioid therapy is preferred for treatment of chronic pain. Opioids should be used only when benefits for pain and function are expected to outweigh risks. Before starting opioids, clinicians should establish treatment goals with patients and consider how opioids will be discontinued if benefits do not outweigh risks. When opioids are used, clinicians should prescribe the lowest effective dosage, carefully reassess benefits and risks when considering increasing dosage to 50 morphine milligram equivalents or more per day, and avoid concurrent opioids and benzodiazepines whenever possible. Clinicians should evaluate benefits and harms of continued opioid therapy with patients every 3 months or more frequently and review prescription drug monitoring program data, when available, for high-risk combinations or dosages. For patients with opioid use disorder, clinicians should offer or arrange evidence-based treatment, such as medication-assisted treatment with buprenorphine or methadone. CONCLUSIONS AND RELEVANCE: The guideline is intended to improve communication about benefits and risks of opioids for chronic pain, improve safety and effectiveness of pain treatment, and reduce risks associated with long-term opioid therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 23 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of primary importance, nonopioid therapy is preferred for treatment of chronic pain. Opioids should be used only when benefits for pain and function are expected to outweigh risks.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When opioids are used, clinicians should prescribe the lowest effective dosage, carefully reassess benefits and risks when considering increasing dosage to 50 morphine milligram equivalents or more per day,”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Several nonpharmacologic and nonopioid pharmacologic treatments were found to be effective for chronic pain in studies ranging in duration from 2 weeks to 6 months48–66 (Table 3).”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Contextual Evidence Review
What the sources say
- Not matchedcites [48]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [49]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [50]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [51]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [52]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [53]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study evaluated long-term (≥1 year) benefit of opioids for chronic pain.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The recommendations in the guideline are voluntary, rather than prescriptive standards. They are based on emerging evidence, including observational studies or randomized clinical trials with notable limitations.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > CONCLUSIONS AND RELEVANCE
None of the sources cited for this claim have been checked yet.
In the paper
“Studies examining patients who underwent low-risk surgery or experienced low back pain from injury revealed that opioid therapy prescribed for acute pain was associated with greater likelihood of long-term use.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Clinical Evidence Review
What the sources say
- Not checked yetcites [46]
- Not checked yetcites [47]
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study evaluated the effectiveness of risk mitigation strategies.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Clinical Evidence Review
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Evidence consisted of observational studies or randomized clinical trials with notable limitations, characterized as low quality using GRADE methodology.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Opioids were associated with increased risks, including opioid use disorder, overdose, and death, with dose-dependent affects.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Before starting opioids, clinicians should establish treatment goals with patients and consider how opioids will be discontinued if benefits do not outweigh risks.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A study of almost 100,000 patients found that the average rate of tapering was 34.0% of the original dose per month and more than a quarter of patients were tapering at a rate faster than 40% of their original dose per month,43,49 even higher than the maximum rate recommended by the CDC. 1”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [1]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, opioids are significantly less effective against chronic pain, such as neuropathic pain, fibromyalgia, and low-back pain, and tolerance develops to the analgesic effects of opioids, thus necessitating the need for increasingly higher doses to sustain analgesia (McQuay, 1988;Dowell et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Dowell et al., 2016
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The influential Centres for Disease Control (CDC) Guideline for Prescribing Opioids recommends a linear reduction of opioid doses: ‘A decrease of 10% of the original dose per week’ or ‘slower tapers (e.g. 10% per month)’ for longer term users (Figure 1(a)). 1”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [1]
In the citing paper
“Opioids are also associated with substantial systemic harm such as worsening psychopathology, addiction, tolerance, and premature death. 24”
From Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome (2021) · cites this paper as [24]
In the citing paper
“The Centers for Disease Control and Prevention and US Food and Drug Administration issued warnings in 2016 to make prescribers and patients aware of these risks.19,34”
From Patterns in Outpatient Benzodiazepine Prescribing in the United States (2019) · cites this paper as [34]
In the citing paper
“evidence of their longterm efficacy and safety is limited.6”
From Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis (2020) · cites this paper as [6]
In the citing paper
“Although opioids are considered to be useful in managing a wide continuum of pain, including acute, procedural, and chronic pain”
From Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis (2020) · cites this paper as [6]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,842
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
Self-citationCDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
Self-citationPsychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Flagged first, then by citations
1 of the 215 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 1,036
Sleep disorders in chronic pain and its neurochemical mechanisms: a narrative review
Duo, L., Yu, X., Hu, R., Duan, X., Zhou, J. J., & Wang, K. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1157790 · Cited by 78
Adewumi, A. D., Hollingworth, S., Maravilla, J. C., Connor, J. P., & Alati, R. (2018) · CNS Drugs · doi:10.1007/s40263-018-0499-3 · Cited by 66
Meghani, S. H., & Vapiwala, N. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1574 · Cited by 66
Manhapra, A., & Becker, W. C. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.013 · Cited by 62
Binge Drinking and Prescription Opioid Misuse in the U.S., 2012–2014
Esser, M. B., Guy, G. P., Zhang, K., & Brewer, R. D. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.02.025 · Cited by 69
Petzke, F. W., Klose, P., Welsch, P., Sommer, C., & Häuser, W. (2019) · European Journal of Pain · doi:10.1002/ejp.1519 · Cited by 65
Mindfulness-Based Cognitive Therapy for Treating Chronic Pain A Systematic Review and Meta-analysis
Pei, J., Ma, T., Nan, R.-L., Chen, H., Zhang, Y., Gou, L., & Dou, X. (2020) · Psychology Health & Medicine · doi:10.1080/13548506.2020.1849746 · Cited by 65
Hansen, R. N., Pham, A. T., Boing, E., Lovelace, B., Wan, G. J., & Miller, T. E. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1297702 · Cited by 65
Nonmedical Use of Prescription Opioids among Pregnant U.S. Women
Kozhimannil, K. B., Graves, A. J., Levy, R. J., & Patrick, S. W. (2017) · Women s Health Issues · doi:10.1016/j.whi.2017.03.001 · Cited by 65
White, P. F. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1289176 · Cited by 65
Opioid‐sparing effects of 10 kHz spinal cord stimulation: a review of clinical evidence
Al-Kaisy, A. A., Buyten, J. V., Amirdelfan, K., Gliner, B. E., Caraway, D. L., Subbaroyan, J., Rotte, A., & Kapural, L. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14236 · Cited by 69
Hurley, R. W., Adams, M. C. B., Barad, M. J., Bhaskar, A., Bhatia, A., Chadwick, A. L., Deer, T. R., Hah, J. M., Hooten, W. M., Kissoon, N. R., et al. (2021) · Pain Medicine · doi:10.1093/pm/pnab281 · Cited by 64
Deyo, R. A., Hallvik, S. E., Hildebran, C., Marino, M., Springer, R. J., Irvine, J. M., O’Kane, N., Otterloo, J. V., Wright, D. A., Leichtling, G. J., et al. (2017) · Journal of Pain · doi:10.1016/j.jpain.2017.10.001 · Cited by 64
Ryan, S. A., & Dunne, R. (2018) · Pain Management · doi:10.2217/pmt-2017-0060 · Cited by 67
Qato, D. M., Zhang, C., Gandhi, A. B., Simoni, J. M., & Coleman‐Cowger, V. H. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107729 · Cited by 71
Osypiuk, K., Ligibel, J. A., Giobbie‐Hurder, A., Vergara-Diaz, G. P., Bonato, P., Quinn, R., Ng, W. T., & Wayne, P. M. (2020) · Integrative Cancer Therapies · doi:10.1177/1534735419893766 · Cited by 64
The opioid crisis in North America: facts and future lessons for Europe
Ayoo, K., Mikhaeil, J. S., Huang, A., & Wąsowicz, M. (2020) · Anaesthesiology Intensive Therapy · doi:10.5114/ait.2020.94756 · Cited by 64
Chedid, V., Brandler, J., Vijayvargiya, P., Park, S.-Y., Szarka, L. A., & Camilleri, M. (2019) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0234-1 · Cited by 65
Patients perceptions of virtual reality therapy in the management of chronic cancer pain
Garrett, B., Tao, G., Taverner, T., Cordingley, E., & Sun, C. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03916 · Cited by 63
Telemedicine for Chronic Pain in the COVID-19 Era and Beyond
Emerick, T. D., Alter, B. J., Jarquin, S., Brancolini, S. A., Bernstein, C., Luong, K., Morrissey, S., & Wasan, A. D. (2020) · Pain Medicine · doi:10.1093/pm/pnaa220 · Cited by 65
Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis
Scuteri, D., Mantovani, E., Tamburin, S., Sandrini, G., Corasaniti, M. T., Bagetta, G., & Tonin, P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.587050 · Cited by 63
Megale, R. Z., Deveza, L. A., Blyth, F., Naganathan, V., Ferreira, P. H., McLachlan, A. J., & Ferreira, M. L. (2017) · Journal of Pain · doi:10.1016/j.jpain.2017.12.001 · Cited by 65
Rice, D., Corace, K., Wolfe, D., Esmaeilisaraji, L., Michaud, A., Grima, A., Austin, B., Douma, R., Barbeau, P., Butler, C., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0244401 · Cited by 64
Seal, K. H., Bertenthal, D., Barnes, D. E., Byers, A. L., Strigo, I., & Yaffe, K. (2017) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2017.03.026 · Cited by 60
Campbell, C. I., Bahorik, A. L., VanVeldhuisen, P., Weisner, C., Rubinstein, A. L., & Ray, G. T. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.01.019 · Cited by 63
Vocal Music Therapy for Chronic Pain: A Mixed Methods Feasibility Study
Low, M. Y., Lacson, C. J., Zhang, F., Kesslick, A., & Bradt, J. (2019) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2019.0249 · Cited by 74
Li, Y., Delcher, C., Wei, Y. J., Reisfield, G. M., Brown, J. D., Tighe, P. J., & Winterstein, A. G. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1807 · Cited by 62
Valente, P. K., Bazzi, A. R., Childs, E., Salhaney, P., Earlywine, J. J., Olson, J., Biancarelli, D. L., Marshall, B. D. L., & Biello, K. B. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102934 · Cited by 61
Renny, M. H., Yin, H. S., Jent, V. A., Hadland, S. E., & Cerdá, M. (2021) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2021.1832 · Cited by 63
Opioids for cancer-related pain in children and adolescents
Wiffen, P. J., Cooper, T. E., Anderson, A.-K., Gray, A. L., Grégoire, M.-C., Ljungman, G., & Zernikow, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012564.pub2 · Cited by 62
Patterns of Opioid Prescribing for an Orthopaedic Trauma Population
Ruder, J. A., Wally, M. K., Oliverio, M., Seymour, R. B., Hsu, J. R., & the PRIMUM Group (2017) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000000834 · Cited by 65
Pharmacists’ Role in Opioid Safety: A Focus Group Investigation
Hartung, D. M., Hall, J., Haverly, S. N., Cameron, D., Alley, L., Hildebran, C., O’Kane, N., & Cohen, D. J. (2017) · Pain Medicine · doi:10.1093/pm/pnx139 · Cited by 64
Arthur, J. A., Edwards, T., Reddy, S., Nguyen, K., Hui, D., Yennurajalingam, S., Park, M., Liu, D., & Bruera, E. D. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0248 · Cited by 62
The Relationship of PROMIS Pain Interference and Physical Function Scales
Kendall, R. W., Wagner, B., Brodke, D. S., Bounsanga, J., Voss, M. W., Gu, Y., Spiker, R., Lawrence, B. D., & Hung, M. (2017) · Pain Medicine · doi:10.1093/pm/pnx310 · Cited by 62
Acupuncture for Cancer Pain and Symptom Management in a Palliative Medicine Clinic
Miller, K., Patel, J. N., Symanowski, J. T., Edelen, C., & Walsh, D. (2018) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909118804464 · Cited by 62
A Quality Framework for Emergency Department Treatment of Opioid Use Disorder
Samuels, E. A., D’Onofrio, G., Huntley, K., Levin, S., Schuur, J. D., Bart, G. B., Hawk, K. F., Tai, B., Campbell, C. I., & Venkatesh, A. K. (2018) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2018.08.439 · Cited by 64
Trends in Opioid Use Among Older Survivors of Colorectal, Lung, and Breast Cancers
Salz, T., Lavery, J. A., Lipitz‐Snyderman, A., Boudreau, D. M., Moryl, N., Gillespie, E. F., & Korenstein, D. R. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.00938 · Cited by 62
Stokes, A., Berry, K. M., Hempstead, K., Lundberg, D. J., & Neogi, T. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17228 · Cited by 63
Gazelka, H. M., Leal, J. C., Lapid, M. I., & Rummans, T. A. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.02.002 · Cited by 67
Decline in opioid prescribing after federal rescheduling of hydrocodone products
Raji, M. A., Kuo, Y., Adhikari, D., Baillargeon, J., & Goodwin, J. S. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4376 · Cited by 61
Pomar, E. M. G., & Finnegan, L. P. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00033 · Cited by 69
Malik, K. M., Imani, F., Beckerly, R., & Chovatiya, R. (2020) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.101339 · Cited by 61
Safer and more appropriate opioid prescribing: a large healthcare system's comprehensive approach
Losby, J. L., Hyatt, J. D., Kanter, M. H., Baldwin, G. T., & Matsuoka, D. (2017) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12756 · Cited by 64
A Health System–Wide Initiative to Decrease Opioid-Related Morbidity and Mortality
Weiner, S. G., Price, C. N., Atalay, A. J., Harry, E. M., Pabo, E. A., Patel, R. K., Suzuki, J., Anderson, S., Ashley, S. W., & Kachalia, A. B. (2018) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2018.07.003 · Cited by 60
Kampitak, W., Tanavalee, A., Ngarmukos, S., & Amarase, C. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.10.009 · Cited by 61
Meisel, Z. F., Lupulescu‐Mann, N., Charlesworth, C. J., Kim, H., & Sun, B. (2019) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2019.04.007 · Cited by 61
Jeffery, M. M., Hooten, W. M., Jena, A. B., Ross, J. S., Shah, N. D., & Karaca‐Mandic, P. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.8325 · Cited by 62
Davis, C. S., Piper, B. J., Gertner, A. K., & Rotter, J. (2019) · Pain Medicine · doi:10.1093/pm/pnz159 · Cited by 58
Jones, C. M., Compton, W. M., Vythilingam, M., & Giroir, B. P. (2019) · JAMA · doi:10.1001/jama.2019.7988 · Cited by 61
Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids
Nielsen, S., Larance, B., & Lintzeris, N. (2017) · JAMA · doi:10.1001/jama.2017.0001 · Cited by 60
Optimizing the management of chronic pain in sickle cell disease
Osunkwo, I., O’Connor, H. F., & Saah, E. N. (2020) · Hematology · doi:10.1182/hematology.2020000143 · Cited by 61
Choo, E. K., Ewing, S. W. F., & Lovejoy, T. I. (2016) · JAMA · doi:10.1001/jama.2016.13677 · Cited by 60
Kleiman, A. M., Sanders, D. T., Nemergut, E. C., & Huffmyer, J. L. (2017) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0000000000000663 · Cited by 63
Gellad, W. F., Thorpe, J. M., Zhao, X., Thorpe, C. T., Sileanu, F. E., Cashy, J., Hale, J. A., Mor, M. K., Radomski, T. R., Hausmann, L. R. M., et al. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.304174 · Cited by 60
Murphy, D. L., Lebin, J. A., Severtson, S. G., Olsen, H. A., Dasgupta, N., & Dart, R. C. (2018) · Drug Safety · doi:10.1007/s40264-018-0660-4 · Cited by 59
Persistent Postoperative Opioid Use in Older Head and Neck Cancer Patients
Saraswathula, A., Chen, M., Mudumbai, S. C., Whittemore, A. S., & Divi, V. (2018) · Otolaryngology · doi:10.1177/0194599818778276 · Cited by 60
Bellampalli, S. S., Ji, Y., Moutal, A., Cai, S., Wijeratne, E. M. K., Gandini, M. A., Yu, J., Chefdeville, A., Dorame, A., Chew, L. A., et al. (2018) · Pain · doi:10.1097/j.pain.0000000000001385 · Cited by 60
Drug Interactions With New Synthetic Opioids
Pérez‐Mañá, C., Papaseit, E., Fonseca, F., Farré, A., Torrens, M., & Farré, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01145 · Cited by 65
Regional and Rural–Urban Variation in Opioid Prescribing in the Veterans Health Administration
Lund, B. C., Ohl, M., Hadlandsmyth, K., & Mosher, H. J. (2019) · Military Medicine · doi:10.1093/milmed/usz104 · Cited by 63
Reddy, S., Orenstein, L. A. V., Strunk, A., & Garg, A. (2019) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.2610 · Cited by 59
The CDC Guideline on Opioid Prescribing
Olsen, Y. K. (2016) · JAMA · doi:10.1001/jama.2016.1910 · Cited by 60
Becker, W. C., DeBar, L. L., Heapy, A. A., Higgins, D., Krein, S. L., Lisi, A., Makris, U. E., & Allen, K. D. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4345-6 · Cited by 59
Opioid Reduction Following Interventional Procedures for Chronic Pain: A Synthesis of the Evidence
Maher, D. P., & Cohen, S. P. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002276 · Cited by 59
Huffman, K. L., Rush, T. E., Fan, Y., Sweis, G. W., Vij, B., Covington, E. C., Scheman, J., & Mathews, M. (2017) · Pain · doi:10.1097/j.pain.0000000000000907 · Cited by 59
Kowalski-McGraw, M., Green-McKenzie, J., Pandalai, S. P., & Schulte, P. A. (2017) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001154 · Cited by 62
Patterns of Potential Opioid Misuse and Subsequent Adverse Outcomes in Medicare, 2008 to 2012
Carey, C. M., Jena, A. B., & Barnett, M. L. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3065 · Cited by 60
Rhon, D. I., Snodgrass, S. J., Cleland, J. A., Sissel, C. D., & Cook, C. E. (2018) · Perioperative Medicine · doi:10.1186/s13741-018-0105-8 · Cited by 60
Dassieu, L., Heino, A., Develay, É., Kaboré, J., Pagé, M. G., Moor, G., Hudspith, M., & Choinière, M. (2021) · Canadian Journal of Pain · doi:10.1080/24740527.2021.1881886 · Cited by 60
The opioid epidemic in pediatrics: a 2020 update
Yaster, M., McNaull, P. P., & Davis, P. J. (2020) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000865 · Cited by 56
Nguyen, A. P., Glanz, J. M., Narwaney, K. J., & Binswanger, I. A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.1018 · Cited by 58
Athanassiou, M., Dumais, A., Zouaoui, I., & Potvin, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1060656 · Cited by 58
Management of Chronic Pain in the Aftermath of the Opioid Backlash
Kroenke, K., & Cheville, A. L. (2017) · JAMA · doi:10.1001/jama.2017.4884 · Cited by 60
Research progress of mechanisms and drug therapy for neuropathic pain
Yan, Y., Li, C.-Y., Zhou, L., Ao, L., Fang, W., & Li, Y. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.09.033 · Cited by 57
Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California
Krebs, E., Enns, B., Evans, E., Urada, D. I., Anglin, M. D., Rawson, R. A., Hser, Y., & Nosyk, B. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0611 · Cited by 62
The Epidemic as Stigma: The Bioethics of Opioids
Buchman, D. Z., Leece, P., & Orkin, A. M. (2017) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110517750600 · Cited by 63
Controlling the Swing of the Opioid Pendulum
Comerci, G. D., Katzman, J. G., & Duhigg, D. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1713159 · Cited by 58
Lin, D. H., Jones, C. M., Compton, W. M., Heyward, J., Losby, J. L., Murimi, I. B., Baldwin, G. T., Ballreich, J. M., Thomas, D. A., Bicket, M. C., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0235 · Cited by 61
Driscoll, M., Knobf, M. T., Higgins, D. M., Heapy, A. A., Lee, A., & Haskell, S. G. (2018) · Pain Medicine · doi:10.1093/pm/pny139 · Cited by 72
Chaudhary, M. A., Bhulani, N., de Jager, E. C., Lipsitz, S. R., Kwon, N. K., Sturgeon, D. J., Trinh, Q., Koehlmoos, T. P., Haider, A. H., & Schoenfeld, A. J. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.6673 · Cited by 58
Zortéa, M., Ramalho, L., Alves, R. L., Alves, C. F. D. S., Braulio, G., Torres, I. L. D. S., Fregni, F., & Caumo, W. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01218 · Cited by 57
Greenberg, J., Popok, P., Lin, A. C., Kulich, R. J., James, P., Macklin, E. A., Millstein, R. A., Edwards, R. R., & Vranceanu, A. (2020) · JMIR Formative Research · doi:10.2196/18703 · Cited by 59
Haroutounian, S., Arendt‐Nielsen, L., Belton, J. L., Blyth, F., Degenhardt, L. J., Forti, M. D., Eccleston, C., Finn, D. P., Finnerup, N. B., Fisher, E., et al. (2021) · Pain · doi:10.1097/j.pain.0000000000002266 · Cited by 66
Thorlund, J. B., Roos, E. M., Goro, P., Ljungcrantz, E. G., Grønne, D. T., & Skou, S. T. (2020) · British Journal of Sports Medicine · doi:10.1136/bjsports-2019-101265 · Cited by 57
Sutherland, T. N., Wunsch, H., Pinto, R. L., Newcomb, C. W., Brensinger, C. M., Gaskins, L. J., Bateman, B. T., & Neuman, M. D. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.11826 · Cited by 57
Mueller, K. G., Memtsoudis, S. G., Mariano, E. R., Baker, L. C., Mackey, S., & Sun, E. C. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002031 · Cited by 57
Prevalence of Long‐Term Opioid Use in Long‐Stay Nursing Home Residents
Hunnicutt, J. N., Chrysanthopoulou, S. A., Ulbricht, C. M., Hume, A. L., Tjia, J., & Lapane, K. L. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15080 · Cited by 56
Barriers to Using Nonpharmacologic Approaches and Reducing Opioid Use in Primary Care
Giannitrapani, K. F., Ahluwalia, S. C., McCaa, M., Pisciotta, M., Dobscha, S. K., & Lorenz, K. (2017) · Pain Medicine · doi:10.1093/pm/pnx220 · Cited by 57
Izrailtyan, I., Qiu, J., Overdyk, F. J., Erslon, M. G., & Gan, T. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194553 · Cited by 62
Opioid Prescribing Practice and Needs in Thyroid and Parathyroid Surgery
Shindo, M. L., Lim, J. Y., León, E. J., Moneta, L. B., Li, R., & Quintanilla‐Dieck, L. (2018) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2018.2427 · Cited by 57
Bhashyam, A. R., Heng, M. M., Harris, M. B., Vrahas, M. S., & Weaver, M. J. (2018) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.17.01400 · Cited by 57
Lozada, M. J., Raji, M. A., Goodwin, J. S., & Kuo, Y. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-05823-0 · Cited by 57
Lee, B., Yang, K.-C., Kaminski, P. C., Peng, S., Odabaş, M., Gupta, S., Green, H. D., Ahn, Y., & Perry, B. L. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.38453 · Cited by 57
Overprescribing of opioids to adults by dentists in the U.S., 2011-2015
Suda, K. J., Zhou, J., Rowan, S. A., McGregor, J. C., Perez, R. I., Evans, C. T., Gellad, W. F., & Calip, G. S. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.11.006 · Cited by 55
Yennurajalingam, S., Edwards, T., Arthur, J. A., Lu, Z., Najera, J., Nguyen, K., Manju, J., Kuriakose, L., Wu, J., Liu, D., et al. (2018) · Cancer · doi:10.1002/cncr.31670 · Cited by 56
Avery, N., McNeilage, A. G., Stanaway, F., Ashton-James, C. E., Blyth, F. M., Martin, R., Gholamrezaei, A., & Glare, P. (2022) · BMJ · doi:10.1136/bmj-2021-066375 · Cited by 56
Walker, C. T., Gullotti, D. M., Prendergast, V., Radosevich, J. J., Grimm, D., Cole, T. S., Godzik, J., Patel, A. A., Whiting, A. C., Little, A. S., et al. (2019) · Neurosurgery · doi:10.1093/neuros/nyz312 · Cited by 56
Neuroimmune modulation of pain and regenerative pain medicine
Buchheit, T., Huh, Y., Maixner, W. D., Cheng, J., & Ji, R. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134439 · Cited by 57
Trends in the Use of Opioids vs Nonpharmacologic Treatments in Adults With Pain, 2011-2019
Pritchard, K. T., Baillargeon, J., Lee, W., Raji, M. A., & Kuo, Y. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.40612 · Cited by 58
Prevalence and correlates of prescription opioid use among US adults, 2019–2020
Zajacova, A., Grol-Prokopczyk, H., Limani, M., Schwarz, C. G., & Gilron, I. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282536 · Cited by 57
Trends in Incident Prescriptions for Behavioral Health Medications in the US, 2018-2022
Chai, G. P., Xu, J., Goyal, S., Woods, C. M., Ho, A., Song, J., & Pan, G. J. D. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.5045 · Cited by 60
Metadata
- Authors
- Dowell, D., Haegerich, T. M., & Chou, R.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Dowell, Deborah
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-04-19
- Volume
- 315
- Issue
- 15
- Pages
- 1624
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC6390846
- OpenAlex
- W2296986887
- Cited by
- 5,161
- References
- 215
- Citations by year
- 2026: 137 · 2025: 233 · 2024: 272 · 2023: 347 · 2022: 407 · 2021: 733 · 2020: 825 · 2019: 762 · 2018: 701 · 2017: 525 · 2016: 214
- FWCI
- 723.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Agency for Healthcare Research and Quality
- U.S. Public Health Service (200-2013-M-53890, 15IPA-1505478, 290201200014I)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- opioid prescribing, chronic pain, opioid use disorder, opioid overdose, benzodiazepines, prescription drug monitoring programs, buprenorphine, methadone, medication-assisted treatment, low-dose opioids, primary care
- MeSH terms
- Contraindications, Adult, Analgesics, Opioid, Benzodiazepines, Centers for Disease Control and Prevention, U.S., Communication, Drug Therapy, Combination, Goals, Humans, Drug Prescriptions, Primary Health Care, United States, Randomized Controlled Trials as Topic, Treatment Outcome, Withholding Treatment, Chronic Pain, Acute Pain, Prescription Drug Misuse, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-24 (prompt extract-v1).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
